|
Boston BioProducts
tris glycine sds running buffer Tris Glycine Sds Running Buffer, supplied by Boston BioProducts, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/Tris-Glycine-SDS+Running+Buffer/pm43015470-805-42-45 Average 94 stars, based on 1 article reviews
tris glycine sds running buffer - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
sds page loading buffer ![]() Sds Page Loading Buffer, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/SDS-PAGE+Sample+Loading+Buffer/pmc13771711-53-0-5 Average 94 stars, based on 1 article reviews
sds page loading buffer - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Bio-Rad
sds ![]() Sds, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/SDS/10__22175_slash_mmb__15701-88-86-93 Average 98 stars, based on 1 article reviews
sds - by Bioz Stars,
2026-11
98/100 stars
|
Buy from Supplier |
|
Carl Zeiss
cirrus 4000 sd-oct instrument ![]() Cirrus 4000 Sd Oct Instrument, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/cirrus+hd+oct+%EB%B9%9B%EA%B0%84%EC%84%AD%EB%8B%A8%EC%B8%B5%EC%B4%AC%EC%98%81%EA%B8%B0+%EC%8A%A4%ED%8E%99%ED%8A%B8%EB%9F%BC%EB%8F%84%EB%A9%94%EC%9D%B8/nct04286217-7-3-2 Average 90 stars, based on 1 article reviews
cirrus 4000 sd-oct instrument - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
sds loading buffer ![]() Sds Loading Buffer, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/Red+Loading+Buffer+Pack/pm43020890-879-25-28 Average 93 stars, based on 1 article reviews
sds loading buffer - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
sd 36 ![]() Sd 36, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/SD-36/pmc13753998-240-12-15 Average 94 stars, based on 1 article reviews
sd 36 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
New England Biolabs
gel loading dye ![]() Gel Loading Dye, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/Gel+Loading+Dye%2C+Purple+(6X)%2C+no+SDS/pm43003089-554-0-4 Average 97 stars, based on 1 article reviews
gel loading dye - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page ![]() Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Sds Page, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/Sodium+dodecyl+sulfate/pm43002103-86-5-23 Average 95 stars, based on 1 article reviews
sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Thermo Fisher
1x mes sds running buffer ![]() 1x Mes Sds Running Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/NuPAGE+MES+SDS+Running+Buffer+(20X)/bio_rxiv__64898__2026__11__04__764245-145-12-26 Average 99 stars, based on 1 article reviews
1x mes sds running buffer - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
R&D Systems
syndecan 4 ![]() Syndecan 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sds/Recombinant+Mouse+Syndecan-4+Protein%2C+CF/bio_rxiv__64898__2026__11__04__764000-311-14-15 Average 90 stars, based on 1 article reviews
syndecan 4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: iScience
Article Title: Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT
doi: 10.1016/j.isci.2026.118212
Figure Lengend Snippet:
Article Snippet:
Techniques:
Journal: Science Advances
Article Title: STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages
doi: 10.1126/sciadv.aek8053
Figure Lengend Snippet: ( A ) Volcano plot showing SD-36–down in IL-6–up genes ( n = 127) and SD-36–up in IL-6–down genes ( n = 18). ( B ) GO analysis of biological processes enriched among the gene sets defined in (A). ( C and D ) RT-qPCR validation of representative SD-36–down in IL-6–up genes (C) and SD-36–up in IL-6–down genes (D) in hMDMs treated with IL-6 for 24 hours with or without SD-36. Data show means ± SD from four independent experiments. * P < 0.05, ** P < 0.01, and **** P < 0.0001 by one-way ANOVA. ( E ) Flow cytometric analysis of total STAT3, pSTAT3 (Tyr 705 ), and pSTAT3 (Ser 727 ) in THP-1–derived macrophages. Data show means ± SD from three independent experiments. * P < 0.05, ** P < 0.01, and *** P < 0.001 by one-way ANOVA. ( F ) Heatmaps of STAT3 binding (CUT&Tag) and H3K27ac enrichment (CUT&Tag) centered on 14,438 STAT3 peaks detected under IL-6 stimulation across R, S, 6, and S6 conditions. ( G and H ) Normalized tag counts for STAT3 (G) and H3K27ac (H) at these 14,438 STAT3 peaks. **** P < 0.0001 by one-way ANOVA. ( I and J ) Log 2 fold change in STAT3 (I) and H3K27ac (J) signal (S6/6) across the eight STAT3 recruitment bins defined in . **** P < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons test. ( K ) Genome browser tracks of STAT3 (green), H3K27ac (blue), and ATAC-seq (pink) signals at a representative SD-36–sensitive locus (bin 7, NAMPT ). Shaded regions indicate STAT3 binding sites. Boxplots show the median, interquartile range, and 10th to 90th percentiles. %TBP, expression normalized to TBP ; R, resting; S, SD-36; 6, IL-6; S6, SD-36 + IL-6.
Article Snippet: After an initial 24 hours of M-CSF conditioning, cells were treated with
Techniques: Analysis, Quantitative RT-PCR, Biomarker Discovery, Derivative Assay, Binding Assay, CUT&Tag, ATAC-seq, Expressing, RNA Sequencing
Journal: Science Advances
Article Title: STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages
doi: 10.1126/sciadv.aek8053
Figure Lengend Snippet: ( A ) Heatmaps showing H3K27ac enrichment (CUT&Tag) centered on 7146 IL-6–induced regions, grouped according to their SD-36 dependency. ( B ) H3K27ac normalized tag counts across resting (R), SD-36 only (S), IL-6 only (6), and IL-6 + SD-36 (S6) conditions, separated by SD-36 dependency. **** P < 0.0001 by one-way ANOVA. ( C ) STAT3 normalized tag counts within the 6355 SD-36–dependent regions, stratified into STAT3 high and STAT3 low groups. **** P < 0.0001 by unpaired t test. ( D ) Heatmaps displaying STAT3 binding (CUT&Tag) centered on SD-36–dependent peaks, stratified into STAT3 high and STAT3 low groups. ( E ) Log 2 fold changes in STAT3 occupancy for IL-6 versus resting (6/R, top) and IL-6 + SD-36 versus IL-6 (S6/6, bottom) between STAT3 high and STAT3 low groups. **** P < 0.0001 by unpaired t test. ( F ) De novo motif enrichment analysis of STAT3 high and STAT3 low regions. ( G ) Log 2 fold changes in expression of genes annotated to STAT3 high and STAT3 low regions (6/R, top; S6/6, bottom). ** P < 0.01 and *** P < 0.001 by unpaired t test. ( H ) Bar plots showing representative gene expression associated with STAT3 high and STAT3 low regions. Data show means ± SD from three biological replicates. * P < 0.05 and *** P < 0.001 by one-way ANOVA. ( I ) Genome browser tracks showing CUT&Tag signals for STAT3 (green), H3K27ac (blue), and ATAC-seq (pink) at representative STAT3 high ( PIM1 ) and STAT3 low ( DTNBP1 ) loci. Shaded regions indicate STAT3 binding sites. Boxplots show the median, interquartile range, and 10th to 90th percentiles. n.s., not significant.
Article Snippet: After an initial 24 hours of M-CSF conditioning, cells were treated with
Techniques: CUT&Tag, Binding Assay, Analysis, Expressing, Gene Expression, ATAC-seq
Journal: Science Advances
Article Title: STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages
doi: 10.1126/sciadv.aek8053
Figure Lengend Snippet: ( A ) Heatmap of SD-36–up genes (IL-6 nonresponsive, increased by SD-36, n = 135) in hMDMs. ( B ) GO terms enriched among SD-36–up genes. ( C ) RT-qPCR of IFIT3 , IRF1 , STAT1 , and STAT2 in hMDMs. Data show means ± SD from four independent experiments. ** P < 0.01 by one-way ANOVA. ( D ) GSEA of HALLMARK_INTERFERON_GAMMA_RESPONSE in S6 versus 6 (NES of 2.178, FDR of <0.001). ( E ) Flow cytometry of total STAT1 and pSTAT1 (Tyr 701 ) in THP-1–derived macrophages (three independent experiments; means ± SD). * P < 0.05 and ** P < 0.01 by one-way ANOVA. ( F ) Heatmaps and boxplots of STAT1 CUT&Tag signal in hMDMs (6 and S6) at regions with increased (up in S6, n = 1852) or decreased (down in S6, n = 889) STAT1 binding. **** P < 0.0001 by paired t test. ( G ) Heatmaps and boxplots of STAT3 CUT&Tag signal in THP-1–derived macrophages (R, 6, and S6) at these regions. **** P < 0.0001 by one-way ANOVA. ( H ) De novo motif enrichment of up in S6 regions, with 16,656 STAT1 consensus regions as background. ( I ) STAT1 CUT&Tag-qPCR at the STAT1 , STAT2 , and OAS1 promoters in hMDMs, shown as log 2 fold enrichment over a STAT1-unbound control region. Points represent donors ( n = 4); lines connect matched measurements. R-6 and 6-S6 comparisons used two-tailed paired t tests. * P < 0.05; n.s., not significant. Both STAT2 comparisons were nonsignificant and are not annotated. ( J ) Genome browser tracks of STAT1 in hMDMs (pink) and STAT3 (green) and H3K27ac (blue) in THP-1–derived macrophages. Boxplots show the median, interquartile range, and 10th to 90th percentiles. %TBP, expression normalized to TBP ; R, resting; S, SD-36; 6, IL-6; S6, SD-36 + IL-6.
Article Snippet: After an initial 24 hours of M-CSF conditioning, cells were treated with
Techniques: Quantitative RT-PCR, Flow Cytometry, Derivative Assay, CUT&Tag, Binding Assay, Control, Two Tailed Test, Expressing, RNA Sequencing, Significance Assay
Journal: Science Advances
Article Title: STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages
doi: 10.1126/sciadv.aek8053
Figure Lengend Snippet: ( A ) Schematic illustrating IL-6 signaling via IL-6Rα and gp130, activating the JAK-STAT3 pathway. Therapeutic inhibitors targeting this axis include the IL-6R-blocking antibody TZ, the JAK inhibitor baricitinib, and the selective STAT3 degrader SD-36. Created in BioRender. J. Lee (2025), https://BioRender.com/8ypkaj9 . ( B ) Schematic illustrating the experimental design for assessing IL-6–induced mRNA changes and the effects of STAT3 degradation (SD-36) and JAK inhibition (baricitinib) in hMDMs. ( C ) Heatmaps showing global expression changes of representative IL-6–induced genes and SD-36–up genes across conditions in hMDMs, revealing three clusters (a, b, and c). ( D ) GO analysis of cluster a (left) and cluster b (right) genes. ( E ) Bar plots showing log 2 FC of the representative genes from cluster a and cluster c under S6 versus 6 (left) and B6 versus 6 (right) comparisons. ( F ) Violin plots showing cluster a (left) and cluster c (right) module scores in monocytes from healthy controls and from patients with COVID-19 before and after TZ treatment ( GSE155223 ). **** P < 0.0001 by two-sided Wilcoxon rank-sum test for the indicated comparisons. ( G ) Dot plots displaying expression of representative genes from cluster a (left) and cluster c (right) modules in healthy controls and in patients with COVID-19 before (TZ before) and after (TZ after) TZ treatment. Dot size indicates the percentage of expressing cells and color intensity reflects average expression. R, resting; 6, IL-6; S6, SD-36 + IL-6; B6, baricitinib + IL-6; TZ, tocilizumab.
Article Snippet: After an initial 24 hours of M-CSF conditioning, cells were treated with
Techniques: Blocking Assay, Inhibition, Expressing, Analysis, RNA Sequencing